<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33114203</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>21</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Oct</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">7877</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21217877</ELocationID>
        <Abstract>
          <AbstractText>Fibromyalgia (FM) is a syndrome that does not present a well-defined underlying organic disease. FM is a condition which has been associated with diseases such as infections, diabetes, psychiatric or neurological disorders, rheumatic pathologies, and is a disorder that rather than diagnosis of exclusion requires positive diagnosis. A multidimensional approach is required for the management of FM, including pain management, pharmacological therapies, behavioral therapy, patient education, and exercise. The purpose of this review is to summarize the recent advances in classification criteria and diagnostic criteria for FM as well as to explore pharmacotherapy and the use of alternative therapies including the use of plant bioactive molecules.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maffei</LastName>
            <ForeName>Massimo E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Life Sciences and Systems Biology, University of Turin, 10135 Turin, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001521" MajorTopicYN="N">Behavior Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000529" MajorTopicYN="N">Complementary Therapies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005356" MajorTopicYN="N">Fibromyalgia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064209" MajorTopicYN="N">Phytochemicals</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alternative therapies</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">fibromyalgia</Keyword>
        <Keyword MajorTopicYN="N">natural products</Keyword>
        <Keyword MajorTopicYN="N">pharmacotherapy</Keyword>
        <Keyword MajorTopicYN="N">plant extracts</Keyword>
      </KeywordList>
      <CoiStatement>The author declares no conflict of interest</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>29</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33114203</ArticleId>
        <ArticleId IdType="pmc">PMC7660651</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms21217877</ArticleId>
        <ArticleId IdType="pii">ijms21217877</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wang S.M., Han C., Lee S.J., Patkar A.A., Masand P.S., Pae C.U. Fibromyalgia diagnosis: A review of the past, present and future. Expert Rev. Neurother. 2015;15:667–679. doi: 10.1586/14737175.2015.1046841.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737175.2015.1046841</ArticleId>
            <ArticleId IdType="pubmed">26035624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chinn S., Caldwell W., Gritsenko K. Fibromyalgia pathogenesis and treatment options update. Curr. Pain Headache Rep. 2016;20:25. doi: 10.1007/s11916-016-0556-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11916-016-0556-x</ArticleId>
            <ArticleId IdType="pubmed">26922414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanco I., Beritze N., Arguelles M., Carcaba V., Fernandez F., Janciauskiene S., Oikonomopoulou K., de Serres F.J., Fernandez-Bustillo E., Hollenberg M.D. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin. Rheumatol. 2010;29:1403–1412. doi: 10.1007/s10067-010-1474-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-010-1474-7</ArticleId>
            <ArticleId IdType="pubmed">20428906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabo-Meseguer A., Cerda-Olmedo G., Trillo-Mata J.L. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med. Clin. 2017;149:441–448. doi: 10.1016/j.medcli.2017.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.medcli.2017.06.008</ArticleId>
            <ArticleId IdType="pubmed">28734619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams D.A., Schilling S. Advances in the assessment of fibromyalgia. Rheum. Dis. Clin. N. Am. 2009;35:339–357. doi: 10.1016/j.rdc.2009.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2009.05.007</ArticleId>
            <ArticleId IdType="pmc">PMC2721827</ArticleId>
            <ArticleId IdType="pubmed">19647147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman A., Underwood M., Carnes D. Fibromyalgia. BMJ Br. Med. J. 2014:348. doi: 10.1136/bmj.g1224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.g1224</ArticleId>
            <ArticleId IdType="pubmed">24566297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBeth J., Mulvey M.R. Fibromyalgia: Mechanisms and potential impact of the acr 2010 classification criteria. Nat. Rev. Rheumatol. 2012;8:108–116. doi: 10.1038/nrrheum.2011.216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrrheum.2011.216</ArticleId>
            <ArticleId IdType="pubmed">22270077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold L.M., Clauw D.J., McCarberg B.H., FibroCollaborative  Improving the recognition and diagnosis of fibromyalgia. Mayo Clin. Proc. 2011;86:457–464. doi: 10.4065/mcp.2010.0738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4065/mcp.2010.0738</ArticleId>
            <ArticleId IdType="pmc">PMC3084648</ArticleId>
            <ArticleId IdType="pubmed">21531887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., et al.  The american-college-of-rheumatology 1990 criteria for the classification of fibromyalgia—Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–172. doi: 10.1002/art.1780330203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.1780330203</ArticleId>
            <ArticleId IdType="pubmed">2306288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dworkin R.H., Turk D.C., McDermott M.P., Peirce-Sandner S., Burke L.B., Cowan P., Farrar J.T., Hertz S., Raja S.N., Rappaport B.A., et al.  Interpreting the clinical importance of group differences in chronic pain clinical trials: Immpact recommendations. Pain. 2009;146:238–244. doi: 10.1016/j.pain.2009.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pain.2009.08.019</ArticleId>
            <ArticleId IdType="pubmed">19836888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold L.M., Crofford L.J., Mease P.J., Burgess S.M., Palmer S.C., Abetz L., Martin S.A. Patient perspectives on the impact of fibromyalgia. Patient Educ. Couns. 2008;73:114–120. doi: 10.1016/j.pec.2008.06.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pec.2008.06.005</ArticleId>
            <ArticleId IdType="pmc">PMC2564867</ArticleId>
            <ArticleId IdType="pubmed">18640807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Hauser W. Fibromyalgia diagnosis and diagnostic criteria. Ann. Med. 2011;43:495–502. doi: 10.3109/07853890.2011.595734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/07853890.2011.595734</ArticleId>
            <ArticleId IdType="pubmed">21770697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F. New american college of rheumatology criteria for fibromyalgia: A twenty-year journey. Arthritis Care Res. 2010;62:583–584. doi: 10.1002/acr.20156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.20156</ArticleId>
            <ArticleId IdType="pubmed">20461781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Hauser W., Katz R.S., Mease P., Russell A.S., Russell I.J., Winfield J.B. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the acr preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 2011;38:1113–1122. doi: 10.3899/jrheum.100594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.100594</ArticleId>
            <ArticleId IdType="pubmed">21285161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oncu J., Iliser R., Kuran B. Do new diagnostic criteria for fibromyalgia provide treatment opportunity to those previously untreated? J. Back Musculoskelet. Rehabil. 2013;26:437–443. doi: 10.3233/BMR-130403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/BMR-130403</ArticleId>
            <ArticleId IdType="pubmed">23948832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Walitt B., Rasker J.J., Hauser W. Primary and secondary fibromyalgia are the same: The universality of polysymptomatic distress. J. Rheumatol. 2019;46:204–212. doi: 10.3899/jrheum.180083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.180083</ArticleId>
            <ArticleId IdType="pubmed">30008459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellato E., Marini E., Castoldi F., Barbasetti N., Mattei L., Bonasia D.E., Blonna D. Fibromyalgia syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Res. Treat. 2012;2012:426130. doi: 10.1155/2012/426130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/426130</ArticleId>
            <ArticleId IdType="pmc">PMC3503476</ArticleId>
            <ArticleId IdType="pubmed">23213512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett R.M., Friend R., Marcus D., Bernstein C., Han B.K., Yachoui R., Deodhar A., Kaell A., Bonafede P., Chino A., et al.  Criteria for the diagnosis of fibromyalgia: Validation of the modified 2010 preliminary american college of rheumatology criteria and the development of alternative criteria. Arthritis Care Res. 2014;66:1364–1373. doi: 10.1002/acr.22301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.22301</ArticleId>
            <ArticleId IdType="pubmed">24497443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal R., Ringold S., Khanna D., Neogi T., Johnson S.R., Miller A., Brunner H.I., Ogawa R., Felson D., Ogdie A., et al.  Distinctions between diagnostic and classification criteria? Arthritis Care Res. 2015;67:891–897. doi: 10.1002/acr.22583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.22583</ArticleId>
            <ArticleId IdType="pmc">PMC4482786</ArticleId>
            <ArticleId IdType="pubmed">25776731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor W.J., Fransen J. Distinctions between diagnostic and classification criteria: Comment on the article by Aggarwal et al. Arthritis Care Res. 2016;68:149–150. doi: 10.1002/acr.22671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.22671</ArticleId>
            <ArticleId IdType="pubmed">26199203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Hauser W., Katz R.L., Mease P.J., Russell A.S., Russell I.J., Walitt B. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016;46:319–329. doi: 10.1016/j.semarthrit.2016.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2016.08.012</ArticleId>
            <ArticleId IdType="pubmed">27916278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bidari A., Parsa B.G., Ghalehbaghi B. Challenges in fibromyalgia diagnosis: From meaning of symptoms to fibromyalgia labeling. Korean J. Pain. 2018;31:147–154. doi: 10.3344/kjp.2018.31.3.147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3344/kjp.2018.31.3.147</ArticleId>
            <ArticleId IdType="pmc">PMC6037812</ArticleId>
            <ArticleId IdType="pubmed">30013729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Treede R.D., Rief W., Barke A., Aziz Q., Bennett M.I., Benoliel R., Cohen M., Evers S., Finnerup N.B., First M.B., et al.  Chronic pain as a symptom or a disease: The IASP classification of chronic pain for the international classification of diseases (ICD-11) Pain. 2019;160:19–27. doi: 10.1097/j.pain.0000000000001384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000001384</ArticleId>
            <ArticleId IdType="pubmed">30586067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F., Schmukler J., Jamal S., Castrejon I., Gibson K.A., Srinivasan S., Hauser W., Pincus T. Diagnosis of fibromyalgia: Disagreement between fibromyalgia criteria and clinician-based fibromyalgia diagnosis in a university clinic. Arthritis Care Res. 2019;71:343–351. doi: 10.1002/acr.23731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.23731</ArticleId>
            <ArticleId IdType="pubmed">30724039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eich W., Bar K.J., Bernateck M., Burgmer M., Dexl C., Petzke F., Sommer C., Winkelmann A., Hauser W. Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome: Updated guidelines 2017 and overview of systematic review articles. Schmerz. 2017;31:231–238. doi: 10.1007/s00482-017-0200-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00482-017-0200-7</ArticleId>
            <ArticleId IdType="pubmed">28421273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raffaeli W., Malafoglia V., Bonci A., Tenti M., Ilari S., Gremigni P., Iannuccelli C., Gioia C., Di Franco M., Mollace V., et al.  Identification of mor-positive b cell as possible innovative biomarker (mu lympho-marker) for chronic pain diagnosis in patients with fibromyalgia and osteoarthritis diseases. Int. J. Mol. Sci. 2020;21:15.  doi: 10.3390/ijms21041499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21041499</ArticleId>
            <ArticleId IdType="pmc">PMC7073128</ArticleId>
            <ArticleId IdType="pubmed">32098316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hackshaw K.V., Aykas D.P., Sigurdson G.T., Plans M., Madiai F., Yu L.B., Buffington C.A.T., Giusti M.M., Rodriguez-Saona L. Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders. J. Biol. Chem. 2019;294:2555–2568. doi: 10.1074/jbc.RA118.005816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA118.005816</ArticleId>
            <ArticleId IdType="pmc">PMC6378985</ArticleId>
            <ArticleId IdType="pubmed">30523152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F. Criteria for fibromyalgia? What is fibromyalgia? Limitations to current concepts of fibromyalgia and fibromyalgia criteria. Clin. Exp. Rheumatol. 2017;35:S3–S5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28406762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walitt B., Nahin R.L., Katz R.S., Bergman M.J., Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. PLoS ONE. 2015;10:e0138024.  doi: 10.1371/journal.pone.0138024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0138024</ArticleId>
            <ArticleId IdType="pmc">PMC4575027</ArticleId>
            <ArticleId IdType="pubmed">26379048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore R.A., Straube S., Aldington D. Pain measures and cut-offs—No worse than mild pain as a simple, universal outcome. Anaesthesia. 2013;68:400–412. doi: 10.1111/anae.12148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/anae.12148</ArticleId>
            <ArticleId IdType="pubmed">23347230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espejo J.A., Garcia-Escudero M., Oltra E. Unraveling the molecular determinants of manual therapy: An approach to integrative therapeutics for the treatment of fibromyalgia and chronic fatigue syndrome/myalgic encephalomyelitis. Int. J. Mol. Sci. 2018;19:19.  doi: 10.3390/ijms19092673.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19092673</ArticleId>
            <ArticleId IdType="pmc">PMC6164741</ArticleId>
            <ArticleId IdType="pubmed">30205597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calandre E.P., Rico-Villademoros F., Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin. Pharmacother. 2015;16:1347–1368. doi: 10.1517/14656566.2015.1047343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14656566.2015.1047343</ArticleId>
            <ArticleId IdType="pubmed">26001183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thorpe J., Shum B., Moore R.A., Wiffen P.J., Gilron I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst. Rev. 2018:2. doi: 10.1002/14651858.CD010585.pub2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD010585.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC6491103</ArticleId>
            <ArticleId IdType="pubmed">29457627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mease P.J., Seymour K. Fibromyalgia: Should the treatment paradigm be monotherapy or combination pharmacotherapy? Curr. Pain Headache Rep. 2008;12:399–405. doi: 10.1007/s11916-008-0068-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11916-008-0068-4</ArticleId>
            <ArticleId IdType="pubmed">18973731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwiatek R. Treatment of fibromyalgia. Aust. Prescr. 2017;40:179–183. doi: 10.18773/austprescr.2017.056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18773/austprescr.2017.056</ArticleId>
            <ArticleId IdType="pmc">PMC5662432</ArticleId>
            <ArticleId IdType="pubmed">29109601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright C.L., Mist S.D., Ross R.L., Jones K.D. Duloxetine for the treatment of fibromyalgia. Expert Rev. Clin. Immunol. 2010;6:745–756. doi: 10.1586/eci.10.64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/eci.10.64</ArticleId>
            <ArticleId IdType="pmc">PMC3056054</ArticleId>
            <ArticleId IdType="pubmed">20828282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006;58:389–462. doi: 10.1124/pr.58.3.2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/pr.58.3.2</ArticleId>
            <ArticleId IdType="pmc">PMC2241751</ArticleId>
            <ArticleId IdType="pubmed">16968947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vries M., van Rijckevorsel D.C.M., Wilder-Smith O.H.G., van Goor H. Dronabinol and chronic pain: Importance of mechanistic considerations. Expert Opin. Pharmacother. 2014;15:1525–1534. doi: 10.1517/14656566.2014.918102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14656566.2014.918102</ArticleId>
            <ArticleId IdType="pubmed">24819592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo E.B. Clinical endocannabinoid deficiency (CECD)—Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuroendocr. Lett. 2004;25 (Reprinted from Neuroendocrinilogy, 2004, 25, 31–39)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15159679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith S.C., Wagner M.S. Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuroendocr. Lett. 2014;35:198–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24977967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munro S., Thomas K.L., Abushaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–65. doi: 10.1038/365061a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/365061a0</ArticleId>
            <ArticleId IdType="pubmed">7689702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skrabek R.Q., Gallmova L., Ethans K., Perry D. Nabilone for the treatment of pain in fibromyalgia. J. Pain. 2008;9:164–173. doi: 10.1016/j.jpain.2007.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2007.09.002</ArticleId>
            <ArticleId IdType="pubmed">17974490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walitt B., Klose P., Fitzcharles M.A., Phillips T., Hauser W. Cannabinoids for fibromyalgia. Cochrane Database Syst. Rev. 2016 doi: 10.1002/14651858.CD011694.pub2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD011694.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC6457965</ArticleId>
            <ArticleId IdType="pubmed">27428009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas A., Baillie G.L., Phillips A.M., Razdan R.K., Ross R.A., Pertwee R.G. Cannabidiol displays unexpectedly high potency as an antagonist of cb1 and cb2 receptor agonists in vitro. Br. J. Pharmacol. 2007;150:613–623. doi: 10.1038/sj.bjp.0707133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0707133</ArticleId>
            <ArticleId IdType="pmc">PMC2189767</ArticleId>
            <ArticleId IdType="pubmed">17245363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumeister D., Eich W., Lerner R., Lutz B., Bindila L., Tesarz J. Plasma parameters of the endocannabinoid system are unaltered in fibromyalgia. Psychother. Psychosom. 2018;87:377–379. doi: 10.1159/000492600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000492600</ArticleId>
            <ArticleId IdType="pubmed">30257256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaufmann I., Schelling G., Eisner C., Richter H.P., Krauseneck T., Vogeser M., Hauer D., Campolongo P., Chouker A., Beyer A., et al.  Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology. 2008;33:676–685. doi: 10.1016/j.psyneuen.2008.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2008.02.009</ArticleId>
            <ArticleId IdType="pubmed">18395993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agarwal N., Pacher P., Tegeder I., Amaya F., Constantin C.E., Brenner G.J., Rubino T., Michalski C.W., Marsicano G., Monory K., et al.  Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 2007;10:870–879. doi: 10.1038/nn1916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1916</ArticleId>
            <ArticleId IdType="pmc">PMC2234438</ArticleId>
            <ArticleId IdType="pubmed">17558404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schley M., Legler A., Skopp G., Schmelz M., Konrad C., Rukwied R. Delta-9-thc based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr. Med. Res. Opin. 2006;22:1269–1276. doi: 10.1185/030079906X112651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1185/030079906X112651</ArticleId>
            <ArticleId IdType="pubmed">16834825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiz J., Duran M., Capella D., Carbonell J., Farre M. Cannabis use in patients with fibromyalgia: Effect on symptoms relief and health-related quality of life. PLoS ONE. 2011;6:5.  doi: 10.1371/journal.pone.0018440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0018440</ArticleId>
            <ArticleId IdType="pmc">PMC3080871</ArticleId>
            <ArticleId IdType="pubmed">21533029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ware M.A., Fitzcharles M.A., Joseph L., Shir Y. The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial. Anesth. Analg. 2010;110:604–610. doi: 10.1213/ANE.0b013e3181c76f70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1213/ANE.0b013e3181c76f70</ArticleId>
            <ArticleId IdType="pubmed">20007734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitzcharles M.A., Ste-Marie P.A., Goldenberg D.L., Pereira J.X., Abbey S., Choiniere M., Ko G., Moulin D.E., Panopalis P., Proulx J., et al.  2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res. Manag. 2013;18:119–126. doi: 10.1155/2013/918216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/918216</ArticleId>
            <ArticleId IdType="pmc">PMC3673928</ArticleId>
            <ArticleId IdType="pubmed">23748251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ste-Marie P.A., Fitzcharles M.A., Gamsa A., Ware M.A., Shir Y. Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. Arthritis Care Res. 2012;64:1202–1208. doi: 10.1002/acr.21732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.21732</ArticleId>
            <ArticleId IdType="pubmed">22730275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Painter J.T., Crofford L.J. Chronic opioid use in fibromyalgia syndrome a clinical review. JCR J. Clin. Rheumatol. 2013;19:72–77. doi: 10.1097/RHU.0b013e3182863447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0b013e3182863447</ArticleId>
            <ArticleId IdType="pubmed">23364665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldenberg D.L., Clauw D.J., Palmer R.E., Clair A.G. Opioid use in fibromyalgia: A cautionary tale. Mayo Clin. Proc. 2016;91:640–648. doi: 10.1016/j.mayocp.2016.02.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mayocp.2016.02.002</ArticleId>
            <ArticleId IdType="pubmed">26975749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baraniuk J.N., Whalen G., Cunningham J., Clauw D.J. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet. Disord. 2004;5:48.  doi: 10.1186/1471-2474-5-48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2474-5-48</ArticleId>
            <ArticleId IdType="pmc">PMC539267</ArticleId>
            <ArticleId IdType="pubmed">15588296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitzcharles M.-A., Faregh N., Ste-Marie P.A., Shir Y. Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study. Pain Res. Treat. 2013;2013:7. doi: 10.1155/2013/898493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/898493</ArticleId>
            <ArticleId IdType="pmc">PMC3614030</ArticleId>
            <ArticleId IdType="pubmed">23577251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng X.M., Robinson R.L., Mease P., Kroenke K., Williams D.A., Chen Y., Faries D., Wohlreich M., McCarberg B., Hann D. Long-term evaluation of opioid treatment in fibromyalgia. Clin. J. Pain. 2015;31:7–13. doi: 10.1097/AJP.0000000000000079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AJP.0000000000000079</ArticleId>
            <ArticleId IdType="pubmed">24480913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang J.M., Lee B.J., Oh T.H., Park D., Kim C.H. Association between initial opioid use and response to a brief interdisciplinary treatment program in fibromyalgia. Medicine. 2019;98:8. doi: 10.1097/MD.0000000000013913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000013913</ArticleId>
            <ArticleId IdType="pmc">PMC6344169</ArticleId>
            <ArticleId IdType="pubmed">30608417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris R.E., Clauw D.J., Scott D.J., McLean S.A., Gracely R.H., Zubieta J.K. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 2007;27:10000–10006. doi: 10.1523/JNEUROSCI.2849-07.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2849-07.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672650</ArticleId>
            <ArticleId IdType="pubmed">17855614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett R.M., Jones J., Turk D.C., Russell I.J., Matallana L. An internet survey of 2596 people with fibromyalgia. BMC Musculoskelet. Disord. 2007;8:27. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829161</ArticleId>
            <ArticleId IdType="pubmed">17349056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilliard P.E., Waljee J., Moser S., Metz L., Mathis M., Goesling J., Cron D., Clauw D.J., Englesbe M., Abecasis G., et al.  Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgeryprevalence of preoperative opioid use and associated patient characteristicsprevalence of preoperative opioid use and associated patient characteristics. JAMA Surg. 2018;153:929–937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6233789</ArticleId>
            <ArticleId IdType="pubmed">29998303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaskell H., Moore R.A., Derry S., Stannard C. Oxycodone for pain in fibromyalgia in adults. Cochrane Database Syst. Rev. 2016:23. doi: 10.1002/14651858.CD012329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD012329</ArticleId>
            <ArticleId IdType="pmc">PMC6457853</ArticleId>
            <ArticleId IdType="pubmed">27582266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruette P., Stuyck J., Debeer P. Neuropathic arthropathy of the shoulder and elbow associated with syringomyelia: A report of 3 cases. Acta Orthop. Belg. 2007;73:525–529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17939486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams E.R., Ford C.M., Simonds J.G., Leal A.K. Blocking peripheral opioid receptors with naloxone methiodide prevents acute and chronic training-induced analgesia in a rat model of fibromyalgia. FASEB J. 2017;31:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermans L., Nijs J., Calders P., De Clerck L., Moorkens G., Hans G., Grosemans S., De Mettelinge T.R., Tuynman J., Meeus M. Influence of morphine and naloxone on pain modulation in rheumatoid arthritis, chronic fatigue syndrome/fibromyalgia, and controls: A double-blind, randomized, placebo-controlled, cross-over study. Pain Pract. 2018;18:418–430. doi: 10.1111/papr.12613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/papr.12613</ArticleId>
            <ArticleId IdType="pubmed">28722815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacLean A.J.B., Schwartz T.L. Tramadol for the treatment of fibromyalgia. Expert Rev. Neurother. 2015;15:469–475. doi: 10.1586/14737175.2015.1034693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737175.2015.1034693</ArticleId>
            <ArticleId IdType="pubmed">25896486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gur A., Calgan N., Nas K., Cevik R., Sarac A.J. Low dose of tramadol in the treatment of fibromyalgia syndrome: A controlled clinical trial versus placebo. Ann. Rheum. Dis. 2006;65:556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullican W.S., Lacy J.R., TRAMAP-ANAG-006 Study Group  Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: A comparative trial. Clin. Ther. 2001;23:1429–1445. doi: 10.1016/S0149-2918(01)80118-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0149-2918(01)80118-1</ArticleId>
            <ArticleId IdType="pubmed">11589258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price D.D., Staud R., Robinson M.E., Mauderli A.P., Cannon R., Vierck C.J. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 2002;99:49–59. doi: 10.1016/S0304-3959(02)00053-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0304-3959(02)00053-2</ArticleId>
            <ArticleId IdType="pubmed">12237183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larabi I.A., Martin M., Fabresse N., Etting I., Edel Y., Pfau G., Alvarez J.C. Hair testing for 3-fluorofentanyl, furanylfentanyl, methoxyacetylfentanyl, carfentanil, acetylfentanyl and fentanyl by lc-ms/ms after unintentional overdose. Forensic Toxicol. 2020;38:277–286. doi: 10.1007/s11419-019-00502-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11419-019-00502-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Comer S.D., Cahill C.M. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci. Biobehav. Rev. 2019;106:49–57. doi: 10.1016/j.neubiorev.2018.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2018.12.005</ArticleId>
            <ArticleId IdType="pmc">PMC7233332</ArticleId>
            <ArticleId IdType="pubmed">30528374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abeles A.M., Pillinger M.H., Solitar B.M., Abeles M. Narrative review: The pathophysiology of fibromyalgia. Ann. Intern. Med. 2007;146:726–734. doi: 10.7326/0003-4819-146-10-200705150-00006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-146-10-200705150-00006</ArticleId>
            <ArticleId IdType="pubmed">17502633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: From sickness responses to pathological pain. J. Intern. Med. 2005;257:139–155. doi: 10.1111/j.1365-2796.2004.01443.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2796.2004.01443.x</ArticleId>
            <ArticleId IdType="pubmed">15656873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalil R.B. Pentoxifylline’s theoretical efficacy in the treatment of fibromyalgia syndrome. Pain Med. 2013;14:549–550. doi: 10.1111/j.1526-4637.2012.01381.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1526-4637.2012.01381.x</ArticleId>
            <ArticleId IdType="pubmed">22568683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polli A., Ghosh M., Bakusic J., Ickmans K., Monteyne D., Velkeniers B., Bekaert B., Godderis L., Nijs J. DNA methylation and brain-derived neurotrophic factor expression account for symptoms and widespread hyperalgesia in patients with chronic fatigue syndrome and comorbid fibromyalgia. Arthritis Rheumatol. 2020 doi: 10.1002/art.41405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.41405</ArticleId>
            <ArticleId IdType="pubmed">32562379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott J.R., Hassett A.L., Brummett C.M., Harris R.E., Clauw D.J., Harte S.E. Caffeine as an opioid analgesic adjuvant in fibromyalgia. J. Pain Res. 2017;10:1801–1809. doi: 10.2147/JPR.S134421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JPR.S134421</ArticleId>
            <ArticleId IdType="pmc">PMC5546775</ArticleId>
            <ArticleId IdType="pubmed">28814895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodman C.W., Brett A.S. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern. Med. 2019;179:695–701. doi: 10.1001/jamainternmed.2019.0086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2019.0086</ArticleId>
            <ArticleId IdType="pubmed">30907944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Micheva K.D., Buchanan J., Holz R.W., Smith S.J. Retrograde regulation of synaptic vesicle endocytosis and recycling. Nat. Neurosci. 2003;6:925–932. doi: 10.1038/nn1114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1114</ArticleId>
            <ArticleId IdType="pubmed">12910242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deitos A., Soldatelli M.D., Dussan-Sarria J.A., Souza A., Torres I.L.D., Fregni F., Caumo W. Novel insights of effects of pregabalin on neural mechanisms of intracortical disinhibition in physiopathology of fibromyalgia: An explanatory, randomized, double-blind crossover study. Front. Hum. Neurosci. 2018;12:14. doi: 10.3389/fnhum.2018.00406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnhum.2018.00406</ArticleId>
            <ArticleId IdType="pmc">PMC6252339</ArticleId>
            <ArticleId IdType="pubmed">30510505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiso T., Moriyama A., Furutani M., Matsuda R., Funatsu Y. Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia. Eur. J. Pharmacol. 2018;827:117–124. doi: 10.1016/j.ejphar.2018.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2018.03.011</ArticleId>
            <ArticleId IdType="pubmed">29530591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerardi M.C., Atzeni F., Batticciotto A., Di Franco M., Rizzi M., Sarzi-Puttini P. The safety of pregabalin in the treatment of fibromyalgia. Expert Opin. Drug Saf. 2016;15:1541–1548. doi: 10.1080/14740338.2016.1242575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14740338.2016.1242575</ArticleId>
            <ArticleId IdType="pubmed">27728981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirakata M., Yoshida S., Tanaka-Mizuno S., Kuwauchi A., Kawakami K. Pregabalin prescription for neuropathic pain and fibromyalgia: A descriptive study using administrative database in Japan. Pain Res. Manag. 2018:10. doi: 10.1155/2018/2786151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/2786151</ArticleId>
            <ArticleId IdType="pmc">PMC6008692</ArticleId>
            <ArticleId IdType="pubmed">29973966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asomaning K., Abramsky S., Liu Q., Zhou X., Sobel R.E., Watt S. Pregabalin prescriptions in the United Kingdom: A drug utilisation study of the health improvement network (thin) primary care database. Int J. Clin. Pr. 2016;70:380–388. doi: 10.1111/ijcp.12791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijcp.12791</ArticleId>
            <ArticleId IdType="pubmed">27028939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferreira-Dos-Santos G., Sousa D.C., Costa J., Vaz-Carneiro A. Analysis of the cochrane review: Pregabalin for pain in fibromyalgia in adults. Cochrane database syst rev. 2016; 9: Cd011790 and 2016; 4: Cd009002. Acta Med. Port. 2018;31:376–381. doi: 10.20344/amp.10433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20344/amp.10433</ArticleId>
            <ArticleId IdType="pubmed">30189165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhusal S., Diomampo S., Magrey M.N. Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc. Patient Saf. 2016;8:13–23. doi: 10.2147/DHPS.S95535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/DHPS.S95535</ArticleId>
            <ArticleId IdType="pmc">PMC4762578</ArticleId>
            <ArticleId IdType="pubmed">26937205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold L.M., Choy E., Clauw D.J., Oka H., Whalen E., Semel D., Pauer L., Knapp L. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr. Med. Res. Opin. 2018;34:1397–1409. doi: 10.1080/03007995.2018.1450743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/03007995.2018.1450743</ArticleId>
            <ArticleId IdType="pubmed">29519159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper T.E., Derry S., Wiffen P.J., Moore R.A. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst. Rev. 2017 doi: 10.1002/14651858.CD012188.pub2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD012188.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC6465053</ArticleId>
            <ArticleId IdType="pubmed">28045473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walitt B., Urrutia G., Nishishinya M.B., Cantrell S.E., Hauser W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst. Rev. 2015:66. doi: 10.1002/14651858.CD011735.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD011735</ArticleId>
            <ArticleId IdType="pmc">PMC4755337</ArticleId>
            <ArticleId IdType="pubmed">26046493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welsch P., Uceyler N., Klose P., Walitt B., Hauser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst. Rev. 2018:111. doi: 10.1002/14651858.CD010292.pub2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD010292.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC5846183</ArticleId>
            <ArticleId IdType="pubmed">29489029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grubisic F. Are serotonin and noradrenaline reuptake inhibitors effective, tolerable, and safe for adults with fibromyalgia? A cochrane review summary with commentary. J. Musculoskelet. Neuronal. Interact. 2018;18:404–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6313046</ArticleId>
            <ArticleId IdType="pubmed">30511944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanderWeide L.A., Smith S.M., Trinkley K.E. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J. Clin. Pharm. Ther. 2015;40:1–6. doi: 10.1111/jcpt.12216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcpt.12216</ArticleId>
            <ArticleId IdType="pubmed">25294655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miki K., Murakami M., Oka H., Onozawa K., Yoshida S., Osada K. Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: A randomized, double-blind, placebo-controlled phase IIa study in Japan. Pain. 2016;157:2089–2096. doi: 10.1097/j.pain.0000000000000622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000000622</ArticleId>
            <ArticleId IdType="pmc">PMC4988084</ArticleId>
            <ArticleId IdType="pubmed">27218868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deboer T. The pharmacologic profile of mirtazapine. J. Clin. Psychiatry. 1996;57:19–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8636062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ottman A.A., Warner C.B., Brown J.N. The role of mirtazapine in patients with fibromyalgia: A systematic review. Rheumatol. Int. 2018;38:2217–2224. doi: 10.1007/s00296-018-4068-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-018-4068-3</ArticleId>
            <ArticleId IdType="pubmed">29860538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rico-Villademoros F., Slim M., Calandre E.P. Amitriptyline for the treatment of fibromyalgia: A comprehensive review. Expert Rev. Neurother. 2015;15:1123–1150. doi: 10.1586/14737175.2015.1091726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737175.2015.1091726</ArticleId>
            <ArticleId IdType="pubmed">26395929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore R.A., Derry S., Aldington D., Cole P., Wiffen P.J. Amitriptyline for fibromyalgia in adults. Cochrane Database Syst. Rev. 2015 doi: 10.1002/14651858.CD011824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD011824</ArticleId>
            <ArticleId IdType="pmc">PMC6447238</ArticleId>
            <ArticleId IdType="pubmed">26146793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Tommaso M., Delussi M., Ricci K., D’Angelo G. Abdominal acupuncture changes cortical responses to nociceptive stimuli in fibromyalgia patients. CNS Neurosci. Ther. 2014;20:565–567. doi: 10.1111/cns.12280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cns.12280</ArticleId>
            <ArticleId IdType="pmc">PMC6493169</ArticleId>
            <ArticleId IdType="pubmed">24836741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karatay S., Okur S.C., Uzkeser H., Yildirim K., Akcay F. Effects of acupuncture treatment on fibromyalgia symptoms, serotonin, and substance p levels: A randomized sham and placebo-controlled clinical trial. Pain Med. 2018;19:615–628. doi: 10.1093/pm/pnx263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pm/pnx263</ArticleId>
            <ArticleId IdType="pubmed">29220534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deare J.C., Zheng Z., Xue C.C.L., Liu J.P., Shang J.S., Scott S.W., Littlejohn G. Acupuncture for treating fibromyalgia. Cochrane Database Syst. Rev. 2013 doi: 10.1002/14651858.CD007070.pub2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD007070.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC4105202</ArticleId>
            <ArticleId IdType="pubmed">23728665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao H.J., Li X., Han M., Liu J.P. Acupoint stimulation for fibromyalgia: A systematic review of randomized controlled trials. Evid. Based Complementary Altern. Med. 2013;2013:1–15. doi: 10.1155/2013/362831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/362831</ArticleId>
            <ArticleId IdType="pmc">PMC3877582</ArticleId>
            <ArticleId IdType="pubmed">24454493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X.C., Chen H., Xu W.T., Song Y.Y., Gu Y.H., Ni G.X. Acupuncture therapy for fibromyalgia: A systematic review and meta-analysis of randomized controlled trials. J. Pain Res. 2019;12:527–542. doi: 10.2147/JPR.S186227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JPR.S186227</ArticleId>
            <ArticleId IdType="pmc">PMC6365227</ArticleId>
            <ArticleId IdType="pubmed">30787631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tesio V., Torta D.M.E., Colonna F., Leombruni P., Ghiggia A., Fusaro E., Geminiani G.C., Torta R., Castelli L. Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res. 2015;67:143–150. doi: 10.1002/acr.22403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.22403</ArticleId>
            <ArticleId IdType="pubmed">25047247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gelonch O., Garolera M., Valls J., Rossello L., Pifarre J. Executive function in fibromyalgia: Comparing subjective and objective measures. Compr. Psychiatry. 2016;66:113–122. doi: 10.1016/j.comppsych.2016.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.comppsych.2016.01.002</ArticleId>
            <ArticleId IdType="pubmed">26995244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu C.E., Yu B., Zhang W., Chen W.H., Qi Q., Miao Y. Effectiveness and safety of transcranial direct current stimulation in fibromyalgia: A systematic review and meta-analysis. J. Rehabil. Med. 2017;49:2–9. doi: 10.2340/16501977-2179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2340/16501977-2179</ArticleId>
            <ArticleId IdType="pubmed">27983739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brighina F., Curatolo M., Cosentino G., De Tommaso M., Battaglia G., Sarzi-Puttini P.C., Guggino G., Fierro B. Brain modulation by electric currents in fibromyalgia: A structured review on non-invasive approach with transcranial electrical stimulation. Front. Hum. Neurosci. 2019;13:14. doi: 10.3389/fnhum.2019.00040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnhum.2019.00040</ArticleId>
            <ArticleId IdType="pmc">PMC6378756</ArticleId>
            <ArticleId IdType="pubmed">30804771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dos Santos V.S., Zortea M., Alves R.L., Naziazeno C.C.D., Saldanha J.S., de Carvalho S.D.R., Leite A.J.D., Torres I.L.D., de Souza A., Calvetti P.U., et al.  Cognitive effects of transcranial direct current stimulation combined with working memory training in fibromyalgia: A randomized clinical trial. Sci Rep. 2018;8:11. doi: 10.1038/s41598-018-30127-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-30127-z</ArticleId>
            <ArticleId IdType="pmc">PMC6102237</ArticleId>
            <ArticleId IdType="pubmed">30127510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eken A., Kara M., Baskak B., Baltaci A., Gokcay D. Differential efficiency of transcutaneous electrical nerve stimulation in dominant versus nondominant hands in fibromyalgia: Placebo-controlled functional near-infrared spectroscopy study. Neurophotonics. 2018;5:15. doi: 10.1117/1.NPh.5.1.011005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1117/1.NPh.5.1.011005</ArticleId>
            <ArticleId IdType="pmc">PMC5584730</ArticleId>
            <ArticleId IdType="pubmed">28894759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuksel M., Ayas S., Cabioglu M.T., Yilmaz D., Cabioglu C. Quantitative data for transcutaneous electrical nerve stimulation and acupuncture effectiveness in treatment of fibromyalgia syndrome. Evid. Based Complementary Altern. Med. 2019;12:362831. doi: 10.1155/2019/9684649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/9684649</ArticleId>
            <ArticleId IdType="pmc">PMC6425376</ArticleId>
            <ArticleId IdType="pubmed">30949223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed S., Plazier M., Ost J., Stassijns G., Deleye S., Ceyssens S., Dupont P., Stroobants S., Staelens S., De Ridder D., et al.  The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: A water pet and EEG imaging study. BMC Neurol. 2018;18:10.  doi: 10.1186/s12883-018-1190-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-018-1190-5</ArticleId>
            <ArticleId IdType="pmc">PMC6233518</ArticleId>
            <ArticleId IdType="pubmed">30419855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutbeyaz S.T., Sezer N., Koseoglu F., Kibar S. Low-frequency pulsed electromagnetic field therapy in fibromyalgia a randomized, double-blind, sham-controlled clinical study. Clin. J. Pain. 2009;25:722–728. doi: 10.1097/AJP.0b013e3181a68a6c.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AJP.0b013e3181a68a6c</ArticleId>
            <ArticleId IdType="pubmed">19920724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Multanen J., Hakkinen A., Heikkinen P., Kautiainen H., Mustalampi S., Ylinen J. Pulsed electromagnetic field therapy in the treatment of pain and other symptoms in fibromyalgia: A randomized controlled study. Bioelectromagnetics. 2018;39:405–413. doi: 10.1002/bem.22127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bem.22127</ArticleId>
            <ArticleId IdType="pubmed">29709070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cruccu G., Garcia-Larrea L., Hansson P., Keindl M., Lefaucheur J.P., Paulus W., Taylor R., Tronnier V., Truini A., Attal N. Ean guidelines on central neurostimulation therapy in chronic pain conditions. Eur. J. Neurol. 2016;23:1489–1499. doi: 10.1111/ene.13103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.13103</ArticleId>
            <ArticleId IdType="pubmed">27511815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knijnik L.M., Dussan-Sarria J.A., Rozisky J.R., Torres I.L.S., Brunoni A.R., Fregni F., Caumo W. Repetitive transcranial magnetic stimulation for fibromyalgia: Systematic review and meta-analysis. Pain Pract. 2016;16:294–304. doi: 10.1111/papr.12276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/papr.12276</ArticleId>
            <ArticleId IdType="pubmed">25581213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thut G., Schyns P.G., Gross J. Entrainment of perceptually relevant brain oscillations by non-invasive rhythmic stimulation of the human brain. Front. Psychol. 2011;2:170. doi: 10.3389/fpsyg.2011.00170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyg.2011.00170</ArticleId>
            <ArticleId IdType="pmc">PMC3142861</ArticleId>
            <ArticleId IdType="pubmed">21811485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber A., Werneck L., Paiva E., Gans P. Effects of music in combination with vibration in acupuncture points on the treatment of fibromyalgia. J. Altern. Complement. Med. 2015;21:77–82. doi: 10.1089/acm.2014.0199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/acm.2014.0199</ArticleId>
            <ArticleId IdType="pubmed">25635925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chesky K.S., Russell I.J., Lopez Y., Kondraske G.V. Fibromyalgia tender point pain: A double-blind, placebo-controlled pilot study of music vibration using the music vibration table. J. Musculoskelet. Pain. 1997;5:33–52. doi: 10.1300/J094v05n03_04.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1300/J094v05n03_04</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naghdi L., Ahonen H., Macario P., Bartel L. The effect of low-frequency sound stimulation on patients with fibromyalgia: A clinical study. Pain Res. Manag. 2015;20:E21–E27. doi: 10.1155/2015/375174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2015/375174</ArticleId>
            <ArticleId IdType="pmc">PMC4325896</ArticleId>
            <ArticleId IdType="pubmed">25545161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janzen T.B., Paneduro D., Picard L., Gordon A., Bartel L.R. A parallel randomized controlled trial examining the effects of rhythmic sensory stimulation on fibromyalgia symptoms. PLoS ONE. 2019;14:19.  doi: 10.1371/journal.pone.0212021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0212021</ArticleId>
            <ArticleId IdType="pmc">PMC6396935</ArticleId>
            <ArticleId IdType="pubmed">30822311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ablin J.N., Hauser W., Buskila D. Spa Treatment (Balneotherapy) for Fibromyalgia—A Qualitative-Narrative Review and a Historical Perspective. Evid. Based Complementary Altern. Med. 2013;2013:638050. doi: 10.1155/2013/638050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/638050</ArticleId>
            <ArticleId IdType="pmc">PMC3747489</ArticleId>
            <ArticleId IdType="pubmed">23983795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neumann L., Sukenik S., Bolotin A., Abu-Shakra M., Amir A., Flusser D., Buskila D. The effect of balneotherapy at the dead sea on the quality of life of patients with fibromyalgia syndrome. Clin. Rheumatol. 2001;20:15–19. doi: 10.1007/s100670170097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s100670170097</ArticleId>
            <ArticleId IdType="pubmed">11254234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mist S.D., Firestone K.A., Jones K.D. Complementary and alternative exercise for fibromyalgia: A meta-analysis. J. Pain Res. 2013;6:247–260. doi: 10.2147/JPR.S32297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JPR.S32297</ArticleId>
            <ArticleId IdType="pmc">PMC3616139</ArticleId>
            <ArticleId IdType="pubmed">23569397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fioravanti A., Perpignano G., Tirri G., Cardinale G., Gianniti C., Lanza C.E., Loi A., Tirri E., Sfriso P., Cozzi F. Effects of mud-bath treatment on fibromyalgia patients: A randomized clinical trial. Rheumatol. Int. 2007;27:1157–1161. doi: 10.1007/s00296-007-0358-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-007-0358-x</ArticleId>
            <ArticleId IdType="pubmed">17520260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda T., Kudo Y., Horiuchi T., Makino N. Clinical and anti-aging effect of mud-bathing therapy for patients with fibromyalgia. Mol. Cell. Biochem. 2018;444:87–92. doi: 10.1007/s11010-017-3233-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-017-3233-4</ArticleId>
            <ArticleId IdType="pubmed">29214470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guidelli G.M., Tenti S., De Nobili E., Fioravanti A. Fibromyalgia syndrome and spa therapy: Myth or reality? Clin. Med. Insights Arthritis Musculoskelet. Disord. 2012;5:19–26. doi: 10.4137/CMAMD.S8797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4137/CMAMD.S8797</ArticleId>
            <ArticleId IdType="pmc">PMC3296493</ArticleId>
            <ArticleId IdType="pubmed">22408369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ernst E., Fialka V. Ice freezes pain—A review of the clinical effectiveness of analgesic cold therapy. J. Pain Symptom Manag. 1994;9:56–59. doi: 10.1016/0885-3924(94)90150-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0885-3924(94)90150-3</ArticleId>
            <ArticleId IdType="pubmed">8169463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera J., Tercero M.J., Salas J.S., Gimeno J.H., Alejo J.S. The effect of cryotherapy on fibromyalgia: A randomised clinical trial carried out in a cryosauna cabin. Rheumatol. Int. 2018;38:2243–2250. doi: 10.1007/s00296-018-4176-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-018-4176-0</ArticleId>
            <ArticleId IdType="pmc">PMC6223856</ArticleId>
            <ArticleId IdType="pubmed">30353267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bettoni L., Bonomi F.G., Zani V., Manisco L., Indelicato A., Lanteri P., Banfi G., Lombardi G. Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients. Clin. Rheumatol. 2013;32:1337–1345. doi: 10.1007/s10067-013-2280-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-013-2280-9</ArticleId>
            <ArticleId IdType="pubmed">23636794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutherland A.M., Clarke H.A., Katz J., Katznelson R. Hyperbaric oxygen therapy: A new treatment for chronic pain? Pain Pract. 2016;16:620–628. doi: 10.1111/papr.12312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/papr.12312</ArticleId>
            <ArticleId IdType="pubmed">25988526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett M.H., French C., Schnabel A., Wasiak J., Kranke P., Weibel S. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database Syst. Rev. 2015 doi: 10.1002/14651858.CD005219.pub3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD005219.pub3</ArticleId>
            <ArticleId IdType="pubmed">26709672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yildiz S., Kiralp M.Z., Akin A., Keskin I., Ay H., Dursun H., Cimsit M. A new treatment modality for fibromyalgia syndrome: Hyperbaric oxygen therapy. J. Int. Med Res. 2004;32:263–267. doi: 10.1177/147323000403200305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/147323000403200305</ArticleId>
            <ArticleId IdType="pubmed">15174219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boussi-Gross R., Golan H., Fishlev G., Bechor Y., Volkov O., Bergan J., Friedman M., Hoofien D., Shlamkovitch N., Ben-Jacob E., et al.  Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury—Randomized prospective trial. PLoS ONE. 2013;8:e79995.  doi: 10.1371/journal.pone.0079995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0079995</ArticleId>
            <ArticleId IdType="pmc">PMC3829860</ArticleId>
            <ArticleId IdType="pubmed">24260334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Efrati S., Golan H., Bechor Y., Faran Y., Daphna-Tekoah S., Sekler G., Fishlev G., Ablin J.N., Bergan J., Volkov O., et al.  Hyperbaric oxygen therapy can diminish fibromyalgia syndrome—Prospective clinical trial. PLoS ONE. 2015;10:e0127012.  doi: 10.1371/journal.pone.0127012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0127012</ArticleId>
            <ArticleId IdType="pmc">PMC4444341</ArticleId>
            <ArticleId IdType="pubmed">26010952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Shewy K.M., Kunbaz A., Gad M.M., Al-Husseini M.J., Saad A.M., Sammour Y.M., Abdel-Daim M.M. Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review. Biomed. Pharmacother. 2019;109:629–638. doi: 10.1016/j.biopha.2018.10.157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2018.10.157</ArticleId>
            <ArticleId IdType="pubmed">30399600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kisselev S.B., Moskvin S.V. The use of laser therapy for patients with fibromyalgia: A critical literary review. J. Lasers Med. Sci. 2019;10:12–20. doi: 10.15171/jlms.2019.02.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15171/jlms.2019.02</ArticleId>
            <ArticleId IdType="pmc">PMC6499579</ArticleId>
            <ArticleId IdType="pubmed">31360363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White P.F., Zafereo J., Elvir-Lazo O.L., Hernandez H. Treatment of drug-resistant fibromyalgia symptoms using high-intensity laser therapy: A case-based review. Rheumatol. Int. 2018;38:517–523. doi: 10.1007/s00296-017-3856-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-017-3856-5</ArticleId>
            <ArticleId IdType="pubmed">29080932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gur A., Karakoc M., Nas K., Cevik R., Sarac A.J., Ataoglu S. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: A single-blind, placebo-controlled trial. Rheumatol. Int. 2002;22:188–193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12215864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panton L., Simonavice E., Williams K., Mojock C., Kim J.S., Kingsley J.D., McMillan V., Mathis R. Effects of class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J. Altern. Complement. Med. 2013;19:445–452. doi: 10.1089/acm.2011.0398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/acm.2011.0398</ArticleId>
            <ArticleId IdType="pubmed">23176373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruaro J.A., Frez A.R., Ruaro M.B., Nicolau R.A. Low-level laser therapy to treat fibromyalgia. Lasers Med. Sci. 2014;29:1815–1819. doi: 10.1007/s10103-014-1566-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10103-014-1566-8</ArticleId>
            <ArticleId IdType="pubmed">24801056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Da Silva M.M., Albertini R., Leal E.C.P., de Carvalho P.D.C., Silva J.A., Bussadori S.K., de Oliveira L.V.F., Casarin C.A.S., Andrade E.L., Bocalini D.S., et al.  Effects of exercise training and photobiomodulation therapy (extraphoto) on pain in women with fibromyalgia and temporomandibular disorder: Study protocol for a randomized controlled trial. Trials. 2015;16:8. doi: 10.1186/s13063-015-0765-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13063-015-0765-3</ArticleId>
            <ArticleId IdType="pmc">PMC4464876</ArticleId>
            <ArticleId IdType="pubmed">26040789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Busch A.J., Webber S.C., Brachaniec M., Bidonde J., Dal Bello-Haas V., Danyliw A.D., Overend T.J., Richards R.S., Sawant A., Schachter C.L. Exercise therapy for fibromyalgia. Curr. Pain Headache Rep. 2011;15:358–367. doi: 10.1007/s11916-011-0214-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11916-011-0214-2</ArticleId>
            <ArticleId IdType="pmc">PMC3165132</ArticleId>
            <ArticleId IdType="pubmed">21725900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones K.D., Adams D., Winters-Stone K., Burckhardt C.S. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988–2005) Health Qual. Life Outcomes. 2006;4:67. doi: 10.1186/1477-7525-4-67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1477-7525-4-67</ArticleId>
            <ArticleId IdType="pmc">PMC1590013</ArticleId>
            <ArticleId IdType="pubmed">16999856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bidonde J., Busch A.J., Schachter C.L., Webber S.C., Musselman K.E., Overend T.J., Goes S.M., Dal Bello-Haas V., Boden C. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst. Rev. 2019:208. doi: 10.1002/14651858.CD013340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD013340</ArticleId>
            <ArticleId IdType="pmc">PMC6931522</ArticleId>
            <ArticleId IdType="pubmed">31124142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assumpção A., Matsutani L.A., Yuan S.L., Santo A.S., Sauer J., Mango P., Marques A.P. Muscle stretching exercises and resistance training in fibromyalgia: Which is better? A three-arm randomized controlled trial. Eur. J. Phys. Rehabil. Med. 2018;54:663–670. doi: 10.23736/S1973-9087.17.04876-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.23736/S1973-9087.17.04876-6</ArticleId>
            <ArticleId IdType="pubmed">29185675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson N.L. Muscle strengthening activities and fibromyalgia: A review of pain and strength outcomes. J. Bodyw. Mov. Ther. 2015;19:370–376. doi: 10.1016/j.jbmt.2014.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbmt.2014.08.007</ArticleId>
            <ArticleId IdType="pubmed">25892394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanudo B., Galiano D., Carrasco L., Blagojevic M., de Hoyo M., Saxton J. Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: A randomized controlled trial. Arch. Phys. Med. Rehabil. 2010;91:1838–1843. doi: 10.1016/j.apmr.2010.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.apmr.2010.09.006</ArticleId>
            <ArticleId IdType="pubmed">21112423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Umeda M., Corbin L.W., Maluf K.S. Pain mediates the association between physical activity and the impact of fibromyalgia on daily function. Clin. Rheumatol. 2015;34:143–149. doi: 10.1007/s10067-013-2386-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-013-2386-0</ArticleId>
            <ArticleId IdType="pubmed">24030630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bement M.K.H., Weyer A., Hartley S., Drewek B., Harkins A.L., Hunter S.K. Pain perception after isometric exercise in women with fibromyalgia. Arch. Phys. Med. Rehabil. 2011;92:89–95. doi: 10.1016/j.apmr.2010.10.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.apmr.2010.10.006</ArticleId>
            <ArticleId IdType="pubmed">21187210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carson J.W., Carson K.M., Jones K.D., Bennett R.M., Wright C.L., Mist S.D. A pilot randomized controlled trial of the yoga of awareness program in the management of fibromyalgia. Pain. 2010;151:530–539. doi: 10.1016/j.pain.2010.08.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pain.2010.08.020</ArticleId>
            <ArticleId IdType="pmc">PMC5568071</ArticleId>
            <ArticleId IdType="pubmed">20946990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Oliveira F.R., Goncalves L.C.V., Borghi F., da Silva L., Gomes A.E., Trevisan G., de Souza A.L., Grassi-Kassisse D.M., Crege D. Massage therapy in cortisol circadian rhythm, pain intensity, perceived stress index and quality of life of fibromyalgia syndrome patients. Complement. Ther. Clin. Pract. 2018;30:85–90. doi: 10.1016/j.ctcp.2017.12.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ctcp.2017.12.006</ArticleId>
            <ArticleId IdType="pubmed">29389485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomas-Carus P., Hakkinen A., Gusi N., Leal A., Hakkinen K., Ortega-Alonso A. Aquatic training and detraining on fitness and quality of life in fibromyalgia. Med. Sci. Sports Exerc. 2007;39:1044–1050. doi: 10.1249/01.mss.0b0138059aec4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1249/01.mss.0b0138059aec4</ArticleId>
            <ArticleId IdType="pubmed">17596770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gusi N., Tomas-Carus P. Cost-utility of an 8-month aquatic training for women with fibromyalgia: A randomized controlled trial. Arthritis Res. Ther. 2008;10:8. doi: 10.1186/ar2377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar2377</ArticleId>
            <ArticleId IdType="pmc">PMC2374450</ArticleId>
            <ArticleId IdType="pubmed">18294367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrade C.P., Zamuner A.R., Forti M., Franca T.F., Tamburus N.Y., Silva E. Oxygen uptake and body composition after aquatic physical training in women with fibromyalgia: A randomized controlled trial. Eur. J. Phys. Rehabil. Med. 2017;53:751–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28382813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bidonde J., Busch A.J., Schachter C.L., Overend T.J., Kim S.Y., Goes S., Boden C., Foulds H.J.A. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst. Rev. 2017 doi: 10.1002/14651858.CD012700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD012700</ArticleId>
            <ArticleId IdType="pmc">PMC6481524</ArticleId>
            <ArticleId IdType="pubmed">28636204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bidonde J., Busch A.J., Webber S.C., Schachter C.L., Danyliw A., Overend T.J., Richards R.S., Rader T. Aquatic exercise training for fibromyalgia. Cochrane Database Syst. Rev. 2014:177. doi: 10.1002/14651858.CD011336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD011336</ArticleId>
            <ArticleId IdType="pubmed">25350761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marske C., Bernard N., Palacios A., Wheeler C., Preiss B., Brown M., Bhattacharya S., Klapstein G. Fibromyalgia with gabapentin and osteopathic manipulative medicine: A pilot study. J. Altern. Complement. Med. 2018;24:395–402. doi: 10.1089/acm.2017.0178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/acm.2017.0178</ArticleId>
            <ArticleId IdType="pubmed">29298077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baptista A.S., Villela A.L., Jones A., Natour J. Effectiveness of dance in patients with fibromyalgia: A randomised, single-blind, controlled study. Clin. Exp. Rheumatol. 2012;30:S18–S23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23020850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assunção J.C., Silva H.J.D., da Silva J.F.C., Cruz R.D., Lins C.A.D., de Souza M.C. Zumba dancing can improve the pain and functional capacity in women with fibromyalgia. J. Bodyw. Mov. Ther. 2018;22:455–459. doi: 10.1016/j.jbmt.2017.09.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbmt.2017.09.022</ArticleId>
            <ArticleId IdType="pubmed">29861249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C.C., Schmid C.H., Fielding R.A., Harvey W.F., Reid K.F., Price L.L., Driban J.B., Kalish R., Rones R., McAlindon T. Effect of tai chi versus aerobic exercise for fibromyalgia: Comparative effectiveness randomized controlled trial. BMJ Br. Med J. 2018;360:14. doi: 10.1136/bmj.k851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.k851</ArticleId>
            <ArticleId IdType="pmc">PMC5861462</ArticleId>
            <ArticleId IdType="pubmed">29563100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cryan J.F., Dinan T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012;13:701–712. doi: 10.1038/nrn3346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn3346</ArticleId>
            <ArticleId IdType="pubmed">22968153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galland L. The gut microbiome and the brain. J. Med. Food. 2014;17:1261–1272. doi: 10.1089/jmf.2014.7000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jmf.2014.7000</ArticleId>
            <ArticleId IdType="pmc">PMC4259177</ArticleId>
            <ArticleId IdType="pubmed">25402818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goebel A., Buhner S., Schedel R., Lochs H., Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008;47:1223–1227. doi: 10.1093/rheumatology/ken140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/ken140</ArticleId>
            <ArticleId IdType="pubmed">18540025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayer E.A., Tillisch K., Gupta A. Gut/brain axis and the microbiota. J. Clin. Investig. 2015;125:926–938. doi: 10.1172/JCI76304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI76304</ArticleId>
            <ArticleId IdType="pmc">PMC4362231</ArticleId>
            <ArticleId IdType="pubmed">25689247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roman P., Estevez A.F., Mires A., Sanchez-Labraca N., Canadas F., Vivas A.B., Cardona D. A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Sci Rep. 2018;8:9. doi: 10.1038/s41598-018-29388-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-29388-5</ArticleId>
            <ArticleId IdType="pmc">PMC6053373</ArticleId>
            <ArticleId IdType="pubmed">30026567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler D. Translational research: Crossing the valley of death. Nature. 2008;453:840–842. doi: 10.1038/453840a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/453840a</ArticleId>
            <ArticleId IdType="pubmed">18548043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nascimento S.D., DeSantana J.M., Nampo F.K., Ribeiro E.A.N., da Silva D.L., Araujo J.X., Almeida J., Bonjardim L.R., Araujo A.A.D., Quintans L.J. Efficacy and safety of medicinal plants or related natural products for fibromyalgia: A systematic review. Evid. Based Complementary Altern. Med. 2013 doi: 10.1155/2013/149468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/149468</ArticleId>
            <ArticleId IdType="pmc">PMC3687718</ArticleId>
            <ArticleId IdType="pubmed">23861696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brownstein M.J. A brief-history of opiates, opioid-peptides, and opioid receptors. Proc. Natl. Acad. Sci. USA. 1993;90:5391–5393. doi: 10.1073/pnas.90.12.5391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.90.12.5391</ArticleId>
            <ArticleId IdType="pmc">PMC46725</ArticleId>
            <ArticleId IdType="pubmed">8390660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benyhe S. Morphine—New aspects in the study of an ancient compound. Life Sci. 1994;55:969–979. doi: 10.1016/0024-3205(94)00631-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0024-3205(94)00631-8</ArticleId>
            <ArticleId IdType="pubmed">8084213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng I.D., Manning B.H., Martin W.J., Fields H.L. An analgesia circuit activated by cannabinoids. Nature. 1998;395:381–383. doi: 10.1038/26481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/26481</ArticleId>
            <ArticleId IdType="pubmed">9759727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sagy I., Schleider L.B.L., Abu-Shakra M., Novack V. Safety and efficacy of medical cannabis in fibromyalgia. J. Clin. Med. 2019;8:12.  doi: 10.3390/jcm8060807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm8060807</ArticleId>
            <ArticleId IdType="pmc">PMC6616435</ArticleId>
            <ArticleId IdType="pubmed">31195754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van de Donk T., Niesters M., Kowal M.A., Olofsen E., Dahan A., van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019;160:860–869. doi: 10.1097/j.pain.0000000000001464.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000001464</ArticleId>
            <ArticleId IdType="pmc">PMC6430597</ArticleId>
            <ArticleId IdType="pubmed">30585986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib G., Artul S. Medical cannabis for the treatment of fibromyalgia. JCR J. Clin. Rheumatol. 2018;24:255–258. doi: 10.1097/RHU.0000000000000702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000000702</ArticleId>
            <ArticleId IdType="pubmed">29461346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib G., Avisar I. The consumption of cannabis by fibromyalgia patients in Israel. Pain Res. Treat. 2018;5:7829427. doi: 10.1155/2018/7829427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/7829427</ArticleId>
            <ArticleId IdType="pmc">PMC6081591</ArticleId>
            <ArticleId IdType="pubmed">30140459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maffei M.E. Plant natural sources of the endocannabinoid (e)-β-caryophyllene: A systematic quantitative analysis of published literature. Int. J. Mol. Sci. 2020;21:6540.  doi: 10.3390/ijms21186540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21186540</ArticleId>
            <ArticleId IdType="pmc">PMC7554841</ArticleId>
            <ArticleId IdType="pubmed">32906779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paula-Freire L.I.G., Andersen M.L., Gama V.S., Molska G.R., Carlini E.L.A. The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine. 2014;21:356–362. doi: 10.1016/j.phymed.2013.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phymed.2013.08.006</ArticleId>
            <ArticleId IdType="pubmed">24055516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gertsch J., Leonti M., Raduner S., Racz I., Chen J.Z., Xie X.Q., Altmann K.H., Karsak M., Zimmer A. Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. USA. 2008;105:9099–9104. doi: 10.1073/pnas.0803601105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0803601105</ArticleId>
            <ArticleId IdType="pmc">PMC2449371</ArticleId>
            <ArticleId IdType="pubmed">18574142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira G.L.D., Machado K.C., Machado K.C., da Silva A., Feitosa C.M., Almeida F.R.D. Non-clinical toxicity of beta-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female swiss mice. Regul. Toxicol. Pharmacol. 2018;92:338–346. doi: 10.1016/j.yrtph.2017.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yrtph.2017.12.013</ArticleId>
            <ArticleId IdType="pubmed">29258925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quintans L.J., Araujo A.A.S., Brito R.G., Santos P.L., Quintans J.S.S., Menezes P.P., Serafini M.R., Silva G.F., Carvalho F.M.S., Brogden N.K., et al.  Beta-caryophyllene, a dietary cannabinoid, complexed with beta-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn. Life Sci. 2016;149:34–41. doi: 10.1016/j.lfs.2016.02.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2016.02.049</ArticleId>
            <ArticleId IdType="pubmed">26883973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., et al.  Cb2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. USA. 2005;102:3093–3098. doi: 10.1073/pnas.0409888102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0409888102</ArticleId>
            <ArticleId IdType="pmc">PMC549497</ArticleId>
            <ArticleId IdType="pubmed">15705714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fidyt K., Fiedorowicz A., Strzadala L., Szumny A. Beta-caryophyllene and beta-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer Med. 2016;5:3007–3017. doi: 10.1002/cam4.816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cam4.816</ArticleId>
            <ArticleId IdType="pmc">PMC5083753</ArticleId>
            <ArticleId IdType="pubmed">27696789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klauke A.L., Racz I., Pradier B., Markert A., Zimmer A.M., Gertsch J., Zimmer A. The cannabinoid cb2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur. Neuropsychopharmacol. 2014;24:608–620. doi: 10.1016/j.euroneuro.2013.10.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.euroneuro.2013.10.008</ArticleId>
            <ArticleId IdType="pubmed">24210682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melo A.J.D., Heimarth L., Carvalho A.M.D., Quintans J.D.S., Serafini M.R., Araujo A.A.D., Alves P.B., Ribeiro A.M., Shanmugam S., Quintans L.J., et al.  Eplingiella fruticosa (Lamiaceae) Essential Oil Complexed with Beta-Cyclodextrin Improves Its Anti-Hyperalgesic Effect in a Chronic Widespread Non-Inflammatory Muscle Pain Animal Model. Food Chem. Toxicol. 2020;135:7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31693914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolara P., Luceri C., Ghelardini C., Monserrat C., Aiolli S., Luceri F., Lodovici M., Menichetti S., Romanelli M.N. Analgesic effects of myrrh. Nature. 1996;379:29. doi: 10.1038/379029a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/379029a0</ArticleId>
            <ArticleId IdType="pubmed">8538737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borchardt J.K. Myrrh: An analgesic with a 4000-year history. Drug News Perspect. 1996;9:554–557.</Citation>
        </Reference>
        <Reference>
          <Citation>Su S.L., Hua Y.Q., Wang Y.Y., Gu W., Zhou W., Duan J.A., Jiang H.F., Chen T., Tang Y.P. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J. Ethnopharmacol. 2012;139:649–656. doi: 10.1016/j.jep.2011.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jep.2011.12.013</ArticleId>
            <ArticleId IdType="pubmed">22178177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee D., Ju M.K., Kim H. Commiphora extract mixture ameliorates monosodium iodoacetate-induced osteoarthritis. Nutrients. 2020;12:17.  doi: 10.3390/nu12051477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu12051477</ArticleId>
            <ArticleId IdType="pmc">PMC7284963</ArticleId>
            <ArticleId IdType="pubmed">32438772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Germano A., Occhipinti A., Barbero F., Maffei M.E. A pilot study on bioactive constituents and analgesic effects of myrliq®, a Commiphora myrrha extract with a high furanodiene content. Biomed. Res. Int. 2017;2017:3804356. doi: 10.1155/2017/3804356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/3804356</ArticleId>
            <ArticleId IdType="pmc">PMC5463107</ArticleId>
            <ArticleId IdType="pubmed">28626756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galeotti N. Hypericum perforatum (St John’s Wort) beyond Depression: A Therapeutic Perspective for Pain Conditions. J. Ethnopharmacol. 2017;200:136–146. doi: 10.1016/j.jep.2017.02.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jep.2017.02.016</ArticleId>
            <ArticleId IdType="pubmed">28216196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan H., Pervaiz A., Intagliata S., Das N., Venkata K.C.N., Atanasov A.G., Najda A., Nabavi S.M., Wang D.D., Pittala V., et al.  The analgesic potential of glycosides derived from medicinal plants. DARU. 2020;28:387–401. doi: 10.1007/s40199-019-00319-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40199-019-00319-7</ArticleId>
            <ArticleId IdType="pmc">PMC7214601</ArticleId>
            <ArticleId IdType="pubmed">32060737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R.Y., Qiu Z., Wang G.Z., Hu Q., Shi N.H., Zhang Z.Q., Wu Y.Q., Zhou C.H. Quercetin attenuates diabetic neuropathic pain by inhibiting mtor/p70s6k pathway-mediated changes of synaptic morphology and synaptic protein levels in spinal dorsal horn of db/db mice. Eur. J. Pharmacol. 2020;882:7. doi: 10.1016/j.ejphar.2020.173266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2020.173266</ArticleId>
            <ArticleId IdType="pubmed">32553736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carvalho T.T., Mizokami S.S., Ferraz C.R., Manchope M.F., Borghi S.M., Fattori V., Calixto-Campos C., Camilios-Neto D., Casagrande R., Verri W.A. The granulopoietic cytokine granulocyte colony-stimulating factor (G-CSF) induces pain: Analgesia by rutin. Inflammopharmacology. 2019;27:1285–1296. doi: 10.1007/s10787-019-00591-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10787-019-00591-8</ArticleId>
            <ArticleId IdType="pubmed">30945072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao X., Wang X.Y., Gui X., Chen L., Huang B.K. Natural flavonoids as promising analgesic candidates: A systematic review. Chem. Biodivers. 2016;13:1427–1440. doi: 10.1002/cbdv.201600060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbdv.201600060</ArticleId>
            <ArticleId IdType="pubmed">27449823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao X.L., Li L., Kandhare A.D., Mukherjee-Kandhare A.A., Bodhankar S.L. Attenuation of reserpine-induced fibromyalgia via ros and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol. Exp. Ther. Med. 2020;19:1343–1355. doi: 10.3892/etm.2019.8328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2019.8328</ArticleId>
            <ArticleId IdType="pmc">PMC6966137</ArticleId>
            <ArticleId IdType="pubmed">32010308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shakiba M., Moazen-Zadeh E., Noorbala A.A., Jafarinia M., Divsalar P., Kashani L., Shahmansouri N., Tafakhori A., Bayat H., Akhondzadeh S. Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial. Avicenna J. Phytomedicine. 2018;8:513–523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6235666</ArticleId>
            <ArticleId IdType="pubmed">30456199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCarberg B.H. Clinical overview of fibromyalgia. Am. J. Ther. 2012;19:357–368. doi: 10.1097/MJT.0b013e3181ff7bee.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MJT.0b013e3181ff7bee</ArticleId>
            <ArticleId IdType="pubmed">21326083</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
